Dr. Richard Noxon Barr is a Overland Park, Kansas based male Ophthalmologist who is specialized in Ophthalmology. Active license number of Dr. Richard Noxon Barr is 11195 for Ophthalmology in Kansas. Dr. Richard Noxon Barr is medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, patients can be prescribed vision services, including glasses and contact lenses.
Complete Profile:
Dr. Richard Noxon Barr speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Ophthalmology
Credentials:
M.D.
Gender:
Male
Practice Address:
#20 Wycklow, Overland Park, Kansas, 66207
Phone:
913-649-1277
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1023267564
NPI Enumeration Date:
09 Sep, 2008
NPI Last Update On:
09 Sep, 2008
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Richard Noxon Barr are as mentioned below.
License Number
Specialization
State
Status
11195
Ophthalmology
Kansas
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
#20 Wycklow, Overland Park, Kansas
Zip:
66207
Phone Number:
913-649-1277
Fax Number:
--
Patients can reach Dr. Richard Noxon Barr at #20 Wycklow, Overland Park, Kansas or can call to book an appointment on 913-649-1277. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.